Skip to main content
Equibles
IMUX logo

IMUX · Immunic, Inc. · Metrics

Track IMUX — free

Use IMUX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMUX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.42 -0.42 (-3.55%) At close · Sep 11
Rebalance outlook locked
Market Cap
$155.82M
Shares
13.64M

IMUX metrics

42 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.42
Market cap
$155.82M

Price action

20 metrics
Price change (1W)
-12.9%
Price change (30D)
-28.9%
Price change (3M)
-17.6%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
68.0%
Annualized volatility (3M)
55.3%
Beta
—
RSI (14D)
27.0
Price vs SMA 50
-22.4%
Price vs SMA 200
—
Avg volume (3M)
203,746
Relative volume
1.6
Average dollar volume
$2.95M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
13.64M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.2
reciprocal yield 81.9%
FCF yield
-56.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-71.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$117.88M
Net income (TTM)
−$111.57M
Trailing 12 months
Diluted EPS (TTM)
$-3.54
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-5.54

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+221.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-87.4%
Return on assets
-70.1%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
—
Free cash flow (TTM)
−$88.05M
Quick ratio
5.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$155.10M
Latest balance sheet
Cash & equivalents
$155.10M
Total assets
$159.17M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$87.72M
Capital expenditures (TTM)
$329,000
R&D (TTM)
$90.64M
SG&A (TTM)
—
Stock compensation (TTM)
$16.17M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
56
13F filer change QoQ
-22
Institutional ownership
63.5%

Short interest

3 metrics
Short interest
10.9%
Latest settlement · 7.7 days to cover
Days to cover
7.7d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1280776 CUSIP 4525EP200 13F (30d) 22 filings 22 filers Visit website Investor relations